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IV Report of the Scientific Committee for Food on foods 
intended for weight control diets 
(Opinion expressed 19 October 1990) 
Terms of reference 
To advise on the use and on the essential requirements of products intended for use in weight 
control diets. 
Documents consulted 
In drafting its opinion the Committee considered the work carried out on the same subject by 
other groups, notably Codex Alimentarius. The Committee examined many published papers in 
the area of obesity and slimming and also received valuable information from the association of 
Dietetic Foods Industry of the EC (IDACE). 
General considerations 
Obesity is defined as an excessive accumulation of fat in the body leading to a body weight 
outside specified normal limits. In quantitative terms obesity is deemed to exist where body 
weight is 20 % above the upper limit of normal range (Bray, 1979; DHSS-MRC, 1976) for a 
given height. An alternative approach is to express the ratio of weight (kg) to the square of 
height (m) to yield the Quetelet or Body Mass Index (BMI) resulting in the following ranges 
which correspond to the generally accepted recommendations of the Fogarty Centre Conference 
on Obesity (Bray, 1979). 
BMI * 
Men Women 
Underweight 
Desirable range 
Overweight 
Obese 
*[BMI =_wi_(kg) 
ht
2 (m) ] 
<20 
>20<25 
>25<30 
>30 
<18 
>18<23 
>23<28 
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The relationship between adverse health effects and body weight is generally regarded as being 
J-shaped although this becomes less obvious when age is considered. In general the greatest 
risks in terms of mortality are associated with obesity in the age range 20-29 years (Royal 
College of Physicians, 1983). The disorders most frequently associated with obesity include 
hypertension, hypercholesterolaemia, diabetes (non-insulin dependent) and gall bladder disease 
(Hautvast & Deurenberg, 1987). Several of the conditions which are found more frequently 
among the obese, are themselves also associated with increased risk of coronary heart disease. 
Nonetheless the relationship between obesity and coronary heart disease remains complex. 
Thus the recent data of Manson et al. (1990) shows that the greater the BMI the greater the 
relative risk of fatal and non-fatal myocardial infarction in women, this occurs to only a 
moderate extent among the normotensive, normocholesterolaemic, non-smoking or the non-
diabetic sub-groups The relationship between body weight and coronary heart disease may 
become clearer in the future as recent work develops on the importance of body fat distribution 
as a risk factor. A high waistthip ratio, indicative of abdominal obesity, has been indicated by 
several longitudinal studies to be an important risk factor for heart disease (Larsson et al. 1984). 
Thus the available evidence clearly indicates that obesity increases the risk of cardiovascular and 
other diseases but account must be taken of age (Andres et al., 1985), of body fat distribution. 
(Larsson et al., 1984) and of the relatively small effect of obesity on heart disease independant 
of smoking, blood pressure, blood cholesterol and adult onset diabetes (Manson et al., 1990). 
The treatment of obesity has long been regarded as an extremely difficult area, leading to a 
plethora of diets promising beauty, virility and longevity at little personal costs, other than 
perhaps monetary. In considering the treatment of obesity, the Council of Scientific Affairs of 
the American Medical Association (1988) concluded that "Despite a multitude of programs 
designed to treat obesity, success in treatment is often difficult to achieve. If a cure for obesity 
is defined as reduction to desired weight for five years, it is more likely that most people will be 
cured of most forms of cancer than obesity". The high relapse rate in the treatment of obesity 
must remain an important factor in evaluating the suitability of a proposed treatment Equally the 
variable health risks associated with obesity must remain an important consideration. A 
treatment with a moderate attendant risk is not acceptable in the treatment of individuals in the 
overweight or even mildly obese category, particularly given the high relapse rate. As the health 
risks associated with obesity increase with the degree of obesity, the acceptance of the risk 
associated with therapy also increases, notwithstanding the high relapse rate. This is reflected in 
the various guidelines for the treatment of obesity. The overweight category (BMI: male 
>25<30, female >23<28) is relatively low risk and can be treated by diet and by exercise. With 
BMI averaging between 30 and 40, more vigorous dietary therapy is required. Above a BMI of 
40, invasive procedures involving small intestinal resection and jaw wiring are often used. Diet 
therapy is nonetheless central to the management of even the most massively obese. 
In the US, the second National Health and Nutrition Examination Survey (NHANES II, 
National Centre for Health Statistics, 1983) showed that about 34 million American women 
aged 20-74 years were overweight (BMI >27.5) of which some 12.5 million were obese (BMI 
>31.7). These figures correspond to about 25 % of the population overweight with some 8% 
obese. 
European data suggest that the incidence of obesity (>120% of ideal weight or BMI >30) is 
considerably less than in the US with values from as low as 2% for young Dutch adults, to 5-
12% for a nationally representative UK sample to 23% in the Mediterranean EC countries 
(James et al, 1988). All of these data contrast with the very large numbers of individuals who Foods intended for weight control diets: 19-10-1990 
regard themselves as fat, some 82% of women of normal weight and some 45% of women 
underweight (Wooley, 1988) which is reflected in the very large numbers of people, male and 
female, who regularly diet. 
Given the huge demand for successful diet it is not surprising that many faddish diets have 
come and gone and indeed come back again. Equally, it is not surprising that industry provides 
energy reduced versions of foods using sugar and fat substitutes and in recent years provides a 
comprehensive diet package which will ensure that an upper limit of energy intake is achieved. 
It is against this background that the Scientific Committee for Food examined the essential 
requirements of foods for particular nutritional uses intended for use in weight control diets. 
The Committee has attempted to strike a cautious balance between the real risks of obesity, the 
risks of the treatment of obesity and the degree of long term efficacy of treatment. 
Categories of products intended for use in weight control diets 
covered in this report 
Products for use in weight control diets can be broadly classified into two main groups. The 
first group of products set out to provide all of the daily nutritional requirements with the 
exception of energy. The degree of energy deficiency allows this groups to be further 
subdivided into those which provide a substantial deficit in energy requirements (very low 
calorie diets) and those which provide a modest deficit in energy (low calorie diets). The second 
group of products are not intended to provide all of the daily nutritional requirements. They can 
also be divided into two categories, those products intended to replace one meal, usually the 
main meal, and those intended to complement a self-selected calorie controlled diet comprised of 
normal foods. 
Each of these four categories will now be reviewed in greater detail. 
Very low calorie diets 
Products very low in calories [less than 800 kcal (3360 kJ) per day and frequendy less 
than 400 kcal (1680 kJ) per day] have come into wide circulation in recent years as 
slimming diets. The earlier products, often referred to as liquid protein diets, were 
associated with a number of fatalities largely due to the low biological value of the 
protein used. Since then, the quality of the protein used in such products has been 
considerably improved. One of the difficulties in evaluating the safety of very low calorie 
diets is the lack of a properly structured study of their widespread clinically unsupervised 
use by the moderately overweight. Reference to the extensive use of very low calorie diet 
as evidence of their safety when widely used by the general public is not an acceptable 
substitute for properly designed clinical studies. Equally, there is inadequate data on the 
long term efficacy of very low calorie diets when used outside the realm of clinical 
investigation units. In a comparison of the treatment of obesity with very low calorie 
diets alone, by behavioural therapy alone or by a combination treatment, Wadden et 
al.,(1988) found a three year relapse rate of 74-87% across treatments with no 
differences in weight loss between treatments. The data available from industry would 
also indicate that only 24-36% of the users of very low calorie diets follow the label 
instructions to consult with a doctor before starting to take such diets and that some 25% Reports of the Scientific Committee for Food: 27th series 
of users of very low calorie diets ignore label instructions not to pursue the diet for 
longer than three weeks (cited in DHSS, 1987). A central and unresolved problem 
surrounding the use of very low calorie diets is the possibility that a disproportionate part 
of the weight loss is derived from lean tissue in some individuals even aner a substantial 
period of adaptation (Atkinson, 1989) and that this loss is greatest among less obese 
individuals (Forbes, 1987). The Committee also noted recent data which showed that in 
a study comparing very low calorie diets (500 kcal or 2100 kJ per day) and a balanced 
deficit diet (1200 kcal or 5040 kJ per day), the rate of weight loss did not differ, (Foster 
et al., 1990). The same group also compared 48 weeks use of a self selected balanced 
deficit diet (1200 kcal/d. or 5040 kJ/d.) against the same diet for 26 weeks commencing 
after a preliminary 22 weeks on a very low calorie diet (420 kcal/d.; 1757 kJ/d.). At the 
end of the 48 weeks study, no significant advantage in terms of weight loss was evident 
in the group partially treated with a very low calorie diet (Wadden et al., 1990). Given the 
continuing concern over the irresponsible uses of very low calorie diets (Wadden et 
al., 1990), the Committee were unanimous in their view that very low calorie diets 
should not be freely available to the general public for weight reduction. The Committee 
feels that given the balance of risk and benefit, for the general population, access to 
commercially prepared products should be limited to those which provide a minimum of 
800 kcal or 3360 kJ per day. Very low calorie diets, providing less than 800 kcal or 
3360 kJ per day should only be available for the properly supervised treatment of severe 
obesity. Accordingly, very low calorie diets should only be available on prescription and 
sold exclusively through pharmacies. Therefore they will not be considered in this report 
which will focus only on the other three categories. 
Category 1. Low calorie diets 
(800-1200 kcal or 3360-5040 kJ per day) 
Weight reduction frequently requires quite long term adherence to low energy diets, even 
when a suitable body weight has been attained maintaining that weight will require re-
introduction of an energy-reduced diet at various intervals. Although these diets are quite 
feasible using ordinary foodstuffs, the constraints of modern lifestyles often make 
commercially prepared, nutritionally complete, low energy diets attractive to many 
people. Industry has responded to this demand by providing a wide range of such 
products from full formula diets to diets comprising a variety of meals. Thus a minimum 
supply of protein, vitamins and minerals must be specified to ensure that energy is the 
only nutrient which is deficient. This category of products should provide energy in the 
range of 800-1200 kcal or 3360 - 5040 kJ per day. 
Category 2. Meal replacement products 
(275-400 kcal or 1155-1680 kJ per meal) 
Many individuals on a low energy diet do not want to replace all their meals by 
commercially designed products. A demand exists for products to replace one meal per 
day, usually the main meal. Such products should therefore contain sufficient quantities 
of minerals, vitamins and protein to ensure that adequate intakes of these nutrients are 
achieved. Products intended to replace one meal per day should be clearly labelled so. 
Manufacturers should advise the consumer as to how other meals might be balanced to 
ensure adequate intake while maintaining overall energy intake in the range of 800-1200 Foods intended for weight control diets: 19-10-1990 
kcal or 3360 - 5040 kJ per day. This category of products should provide energy in the 
range of 275-400 kcal or 1155-1680 kJ per meal. 
Category 3. Products intended to complement a calorie controlled 
diet which is freely selected from normal foods 
(125 kcal or 525 kJ per item) 
A number of products are available on the market which are intended to help individuals 
follow a calorie controlled diet. These nutrient dense products are frequently in the form 
of bars, biscuits, snacks etc. They are intended to help individuals who are following 
their own diet to eat products which are low in energy but rich in protein, minerals, 
vitamins and in some instances, in fibre. These products should provide less than 125 
kcal per unit or 525 kJ per unit. 
Compositional standards of products intended for use 
in weight control diets 
Energy 
Weight loss requires that energy expenditure should be higher than intake. Energy 
expenditure at rest is proportional to lean body mass and is about 1 kcal or 4.2 kJ per 
minute for the average person and equivalent to about 1500 kcal or 6300 kJ per day. 
Thus most slimming diets aim to provide about 1000 kcal or 4200 kJ per day. The 
Committee accepted a deviation of 20% from this for products intended to replace all 
meals, giving an energy range of 800-1200 kcal or 3360-5040 kJ for such products. 
Single meal replacements have their energy range set at about one third of these values, 
ie. 275-400 kcal or 1155-1680 kJ per meal. The value of 125 kcal or 525 kJ per item for 
products intended to complement a freely selected low energy diet was chosen to ensure 
that such products would be clearly distinguishable from meal replacement products. 
Protein 
Individuals following an energy reduced diet should ensure that protein intake is 
adequate to maintain nitrogen balance. The current adult safe protein allowance is 0.75 
g/kg body weight per day (FAO/WHO/UNU 1985). This translates into a value of about 
50 g/d for the average person of 70 kg body weight. Where products are intended to 
replace all the day's meals, protein should be provided at a level of 50 g per day which 
corresponds to about 20% of energy. This value of 50 g is a minimum for good quality 
protein i.e. 100% of the reference protein (FAO/WHO/UNU 1985). It may be increased 
if the biological value of the protein is lower, although the biological value should never 
be lower than 80 % of the reference protein. For such products, intended to replace all of 
the days meals, an upper limit of 50% of dietary energy from protein is set This is partly 
to ensure that a reasonable balance of lipids and carbohydrate should be allowed in the 
products and also to ensure that the renal load of nitrogenous waste is not excessive. Reports of the Scientific Committee for Food: 27th series 
Products intended to replace one meal per day should contain a minimum of at least a 
third of the daily requirement for protein i.e. 17 g, and of the same quality as described 
for the low calorie products. This minimum of 17 g of protein per meal ensures that 
should such products be improperly taken to replace all of the day's meals, adequate 
intakes of protein will be guaranteed. Again, an upper limit of 50% of dietary energy 
from protein for meal replacement products is set to ensure a good balance of 
carbohydrates and lipids. 
In the case of nutrient dense products intended to be used as a supplement to energy 
reduced diets, the protein content should be higher than that proposed for other 
categories. This recommendation is based on the fact that such products are intended to 
have a high nutrient density to allow people following a self selected slimming diet to 
achieve a good intake of proteins, minerals and vitamins. Thus the Committee 
recommends that the protein should provide between 30 and 50% of the energy of such 
products giving a range per product of 10-15 grams. The proteins should be of the same 
quality as that defined for other products. 
Lipids 
Generally speaking it was considered desirable by the Committee that the fat content 
should not exceed 30% of dietary energy for any of the product categories considered. 
An adequate intake of essential fatty acids should be maintained. A figure of 2-3 % of 
energy from essential fatty acids is generally considered to be sufficient to meet the needs 
of most individuals. Thus in products intended to provide all of the day's nutritional 
requirements, a minimum intake of 4.5 g per day of cis-cis linoleic acid should be 
provided. This is based on the normal average intake of 2,000 kcals or 8.4 MJ per day to 
provide 2.0 % of energy from linoleic acid. For products intended to replace one meal, 
the minimum level of linoleic acid should be 1.5 g per serving which could be provided 
by about 4 g of an appropriate vegetable oil rich in polyunsaturated fatty acids and which 
would remain within the constraints of 30% of energy from fat. In the case of products 
intended to complement a freely selected low-energy diet, the Committee did not feel that 
specific recommendations should be set. 
Carbohydrate and sugar alcohols 
Having set limits on the level of proteins and lipids which may be included in the various 
product categories, the remaining energy can be provided by carbohydrates. The calorie 
content of sugar alcohols (polyols) which may be used in such products cannot be 
ignored and the Committee recommends that for calculation purposes, the sugar alcohols 
be considered to have an energy value of 2.4 kcal/g ( 10 kJ). Where the intake of polyols 
may exceed 20 g per day, this should be stated on the label which should also advise 
consumers that consumption of the product may have a laxative effect. 
Fibre 
There is at present a controversy as to the best method for defining fibre. The definition 
depends on whether fibre is defined by its chemical composition (Englyst method) or by 
its physiological function in the large intestine (Southgate method). The chemical 
definition confines fibre to the non-starch polysaccharides (with or without lignin). The 
physiological definition confines fibre to that fraction of the dietary carbohydrates Foods intended for weight control diets: 19-10-1990 
(including lignin) which cannot be digested in the small intestine and which is available, 
in part at least, for fermentation by colonic anaerobes. The by-products of this 
fermentation may be absorbed across the colon and be available for subsequent 
metabolism. This definition of fibre includes certain fractions of starch which are 
resistant to hydrolysis by pancreatic amylase. These resistant starches may occur 
naturally in foods or may arise in cooking or during manufacture. Given the problem of 
properly defining fibre, the Committee proposes for the moment to use the physiological 
definition of fibre based on the Southgate method pending a detailed report on the matter 
by the Scientific Committee for Food. 
The Committee recommends that to avoid constipation on the one hand and on the other 
the temptation to produce very bulky foods with excessive fibre levels, a minimum and 
maximum value should be set. Accordingly the Committee proposes a range of 10-30 g 
of dietary fibre per day for products intended to provide all of the day's meals. In the 
case of products intended to replace one meal, it may not be technologically possible to 
include fibre to the minimum level of 10 g/1000 kcal or 4200 kJ. Where this arises the 
products should carry a clear statement advising that the product does not contain 
adequate fibre and that fibre should be obtained from other sources. In the case of 
products intended to complement a self selected low energy diet, the Committee did not 
feel that specific recommendations for dietary fibre should be set. 
Minerals and vitamins 
The Scientific Committee for Food is currently detailing recommended dietary 
allowances (RDA's) for use in the European Community. Thus while the guidelines in 
this report approximate the generally accepted values for RDA's currendy in operation in 
the European Community, the Committee recommends that these be modified when the 
work of the Committee on RDA's has been completed. Thus the following minimum 
values are set for products intended to replace the normal diet. 
Units per 1000 kcal (4200 kJ) 
Calcium 
Magnesium 
Potassium 
Sodium 
Iron 
Zinc 
Iodine 
Phosphorus 
800 mg 
300 mg 
1500 mg 
1500 mg 
14 mg 
14 mg 
140 μδ 
800 mg 
Vitamin A * 
Vitamin D 
Vitamin E 
Vitamin C 
Thiamin 
Riboflavin 
Niacin 
Vitamin B6 
Folic acid 
Vitamin Β12 
800 μg 
2.5 μ8 
10 mg 
50 mg 
1.4 mg 
2.0 mg 
24 mg 
2 mg 
100 μδ 
* Retinol equivalent 8 Reports of the Scientific Committee for Food: 27th series 
For products intended to replace only one meal, one third of these requirements must be 
met per meal. In the case of products intended to complement a self selected low energy 
diet one fifth of requirements for Ca, Fe, vitamins A, D, E, thiamine, riboflavin and Be 
should be met per product. For each product category, the levels of vitamins A and D 
should not exceed twice the specified minimum requirement. 
Labelling and claims 
The Committee recommends that each category of product be clearly labelled, so that 
consumers do not confuse one category for another. Other than those intended to supply 
all nutrients for the day, all products should clearly warn consumers to obtain the rest of 
their nutrients from ordinary foods. In the case of the products intended to replace all of 
the day's meals, the product label should advise that this type of diet should not be taken 
for more than three consecutive weeks as the sole source of nutrition without seeking 
medical advice. 
In the case of products intended to replace all of the day's meals, the distribution of 
nutrients in each portion need not be specified provided that the macronutrients are 
reasonably diversified across the various components of the daily ration. However, each 
component of the product should clearly state that it is to be used as directed in 
conjunction with all other components of the product. Where products are free of lactose 
this may be stated on the label. Foods intended for weight control diets: 19-10-1990 
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Annex 
Compositional standards of products intended for use in weight 
control diets 
Energy 
Protein («0 (minimum) 
Cis-cis linoleic acid 
Total fat (% energy) 
Dietary fibre 0») 
Calcium 
Magnesium 
Potassium 
Sodium 
Iron 
Zinc 
Iodine 
Phosphorus 
Vitamin A (0 
Vitamin D 
Vitamin E 
VitaminC 
Thiamin 
Riboflavin 
Niacin 
Vitamin BO 
Folic Acid 
Vitamin Β i2 
kcal 
kJ 
(g) 
(g) 
(g) 
(mg) 
(mg) 
(mg) 
(mg) 
(mg) 
(mg) 
<W> 
(mg) 
(μ«) 
(M) 
(mg) 
(mg) 
(mg) 
(mg) 
(mg) 
(mg) 
(W> 
(W> 
Category 1 
To provide all the 
daily nutrients in 
a low energy diet 
units per day 
800-1200 
3360-5040 
50 
4.5 
<30 
10-30 
800 
300 
1500 
1000 
14 
14 
140 
800 
800 
2.5 
10 
50 
1.4 
2.0 
24 
2.0 
100 
1.0 
Category 2 
To replace one 
meal per day 
units per meal 
275-400 
1155-1680 
17 
1.5 
<30 
10/1000 kcal (d) 
270 
100 
500 
350 
5 
5 
47 
270 
270 
0.8 
3 
17 
0.5 
0.7 
8 
0.7 
33 
0.3 
Category 3 
To complement 
a self-selected 
low energy diet 
units per product 
<125 
<525 
10 
NS 
NS 
NS 
160 
NS 
NS 
NS 
2.8 
NS 
NS 
NS 
160 
0.5 
2 
NS 
0.3 
0.4 
NS 
0.4 
NS 
NS 
(a) 100% of the Reference Protein (FAO/WHO/UNU 1985) 
(b) As determined by the Southgate method 
(c) Retinol Equivalents 
(d) If technologically not possible, statement on labelling about necessity to obtain fibre from 
other sources 
NS = non specified Guidelines for the presentation of data on food 
enzymes 
(opinion expressed 11 April 1991) 
Introduction 
These guidelines cover enzyme preparations intended for use in the preparation of food. Some 
enzyme preparations are used as processing aids and others as true food additives. Whilst this 
distinction may be of administrative importance, from a toxicological point of view it is not 
pertinent to distinguish between these two categories since, in both cases, the enzyme 
preparations may remain in the food 
These guidelines should be considered as setting out the minimum requirements for information 
to be supplied to the Scientific Committee for Food (SCF) in connection with any request for an 
evaluation of the safety in use of an enzyme preparation. If, for a specific enzyme preparation, 
some of the requirements are considered irrelevant, they may be omitted provided satisfactory 
supporting arguments are presented. 
The safety issues involved in the use of enzyme preparations can roughly be split into the 
following categories: 
1. Toxicological properties of the enzyme preparation (i.e. the active enzyme as 
such and any byproducts and contaminants). Care should be taken to ensure that toxic 
contaminants are not present in the enzyme preparation (e.g. mycotoxins and antibiotics 
in enzymes of microbial origin). 
In order to ensure a consistent and safe product there is a need: 
a) for process specifications including appropriate quality assurance checks; 
and 
b) to ensure that the characteristics of the source material or organism do not change with 
time. 
2 . Quantity of enzyme consumed. This in turn depends on the amount added to food, 
the concentration in the food when consumed, the number of different foods in which it 
may be used and the frequency with which these foods are consumed. 14 Reports of the Scientific Committee for Food: 27th series 
3. Allergies and irritations caused by enzyme activity in the final product. 
This is primarily considered to be an occupational health problem when workers are 
handling concentrated enzyme preparations. There are no confirmed cases of allergies 
induced in consumers through intake of enzyme treated food. 
4. Unintended reaction products in the food caused by enzymatic reactions 
in the final foodstuffs (e.g. transformation of histidine to histamine). The possibility 
of any adverse health effects from this cause should be addressed in the submission. 
5. Safety of the source organism (microbials). The use of pathogenic 
microorganisms is primarily of occupational concern as viable cells from the source 
organism should not be present in the final commercial enzyme, but as a general 
principle pathogenic microorganisms should not be used in tile production of food 
enzymes 
With regard to the toxicological properties of enzyme preparations, enzymes which are 
derived from edible parts of plants and animals are generally considered as posing no health 
problems. No special documentation for safety need be supplied provided that the potential 
consumption following normal use does not lead to an intake of any components which is 
larger than can be expected from normal consumption of the source as such, and provided that 
satisfactory chemical and microbiological specifications can be established. 
For enzymes derived from microorganisms, it is very important to ensure that the source does 
not produce toxic compounds which can remain in the final product. It is important to carry out 
toxicological test programmes on all the individual strains used in the production of specific 
enzyme preparations since: 
1. Different strains belonging to the same species can behave differently. For many 
microorganisms it is known that some of the strains in one species are harmless, while 
others belonging to the same species are toxic. 
2. For some fungal genera, especially Pénicillium and Aspergillus, there have been many 
misidentifications of fungal isolates. As a consequence of this, there is a risk of 
misclassification of fungal strains. For example in some cases it has been difficult to 
distinguish A. oryzae from A. flavus which has the ability to produce anatoxin. As 
long as there is a risk of misidentification of microbial isolates, it is very important that 
the microorganism used is correctly identified and, in case of doubt, the identity 
should be verified by an independent, recognized laboratory. 
3. The ability of a microorganism to produce toxins depends - qualitatively and 
quantitatively - on environmental factors such as the composition of fermentation 
media, pH, temperature and fermentation period. Therefore there is a risk that a 
microorganism which does not produce toxins under some conditions will turn out to 
be toxin-producing under other conditions. 
4. The continuous selection processes applied to source microorganisms in order to 
maximize and optimize enzyme production may result in spontaneous mutations which 
give rise to the possibility of changing a non-toxic strain to a toxic strain. 
5. There is a considerable potential to apply new techniques of genetic modification in the 
production of food enzymes. Along with the introduction of desirable traits, there is 
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explicitly to characterize and evaluate the genetic construct as to host, vector and insert 
(see section 2.4 under "Information to be supplied"). 
Information to be supplied for the evaluation of an enzyme 
preparation to be used in foodstuffs 
Administrative data 
Name of applicant, manufacturer(s) of enzyme and person responsible for the dossier. 
Technical data 
1. Active components 
1.1 The principal enzyme activities are to be characterized by their systematic names 
and Enzyme Commission numbers, ι 
1.2 The activity of the enzyme preparations should be measured according to the 
reaction catalysed by individual enzymes and should usually be expressed in activity 
units per unit weight or volume of preparation as appropriate. In commercial practice the 
activity of the product is sometimes also given as the quantity of the enzyme preparation 
to be added to a given quantity of food in order to achieve the desired effect. 
1.3 A list of subsidiary enzymatic activities, whether they perform a useful function 
or not. 
2. Source materials 
If any specific source is likely to contain substances which may be harmful to health, the 
absence of such substances in the enzyme preparation shall be shown (see section 8.6). 
2.1 Animal sources. The animal and the part of the animal used in the preparation must be 
identified. Animal tissues used for the preparation of enzymes must comply with meat 
inspection requirements and be handled in accordance with good hygienic practice. 
2.2 Plant sources. The plant and the part of the plant used in the preparation must be 
identified. 
2.3 Microbial sources used in the production of enzyme preparation can be native strains 
or variants of microorganisms, or be derived from native strains or variants by the 
process of selective serial culture or genetic modification. They must be discrete and 
stable strains or variants which are sufficiently well characterized according to well 
accepted identification keys, to enable them to be assigned unique identities as the 16 Reports of the Scientific Committee for Food: 27th series 
sources of the enzyme preparations which are the subject of individual specifications (see 
point 2 relating to enzymes derived from microorganisms in "Introduction"). 
The type cultures of the production microorganisms must be maintained under conditions 
which ensure the absence of strain drift and when prepared for use in the production of 
enzyme preparations they must be subjected to methods and culture conditions which 
ensure consistency and reproducibility from batch to batch. These procedures must 
ensure the absence of toxin production by the source organism and prevent the 
introduction of foreign microorganisms which could be the source of toxic materials and 
other undesirable substances in the final enzyme products. 
2.4 Genetically modified organisms. The specification shall contain information about 
the host organism, the vector (plasmid) and the DNA-sequence incorporated in the vector 
or in the chromosome. Whether plant, animal or microorganism, the donor organism 
should also be identified. 
It is important to have detailed knowledge of the genetic structures involved so that any 
undesirable interaction between the original genetic material of the host and the new 
genetic material to be inserted can be anticipated. Data on genetic structure such as 
information on presence of extra DNA (plasmids or foreign DNA incorporated in the 
host chromosome), specific genetic characteristics ("markers"), presence of dormant 
genes (which can be expressed by mutations), genetic stability (mutation rate and factors 
influencing the mutation rate, inter- and intramolecular recombinations, restriction 
barriers), gene transfer (mobilization/conjugation ability) and resistances (antibiotics, 
heavy metals) will assist in the prediction of undesirable effects on human health, 
animals, plants and ecological behaviour. 
Exact knowledge of the identity and the biology of the vectors forms the basis for the 
evaluation of whether the introduction of the vector increases or reduces the safety level 
of the host microorganism. A vector should be characterized at the DNA level (size, 
restriction map and possibly full DNA sequence) and genetically with respect to genes 
found on the vector and which could be used as marker genes. A vector must be free of 
harmful sequences as well as non-conjugative and non-mobilizable. 
The DNA sequence(s) to be inserted in the host organism has (have) to be fully 
characterized both at the molecular level and in terms of the number of inserted genes, 
type of regulation (promotor activity) and actual gene product(s). Whether the DNA 
sequence originates from a microorganism, plant or animal, the exact origin and pedigree 
of the genetic construct has to be given in order to enable a proper safety evaluation to be 
carried out. 
Each recombinant product is to be evaluated on a case-by-case basis considering the 
host, the vector and the insert and taking into account that the potential hazard from the 
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3. Manufacturing process 
3.1 Adequate information on the method of manufacture. For microbial sources 
information on fermentation media and conditions are considered essential. All 
components used must be of food grade quality. 
3.2 Adequate information on the purification procedure shall be given. 
If changes occur in the manufacturing process or in the purification of the enzyme 
preparation it will be considered as new unless it can be demonstrated that the final 
product can be considered the same as that prepared by the original procedures. 
4. Carriers and other additives and ingredients 
4.1 Informations on carriers, diluents, excipients, supports and other additives 
and ingredients (including processing aids) used in the production, distribution, and 
applications of enzyme preparations must be given. They must be substances that are 
acceptable for the relevant food-uses of the enzyme preparations concerned, or 
substances which are insoluble in food and removed from the food material after 
processing and before consumption. 
4.2 In the case of immobilized enzyme preparations, the carriers and immobilization 
agents used should be acceptable for the relevant use. When new materials are being 
considered, they should be tested to prove that no harmful residues will leak out into the 
food. Tests should be performed showing that any leakage of immobilization agents or 
enzymes is kept within acceptable limits as specified in the individual specifications. 
4.3 In order to distinguish the proportion of the enzyme preparation derived from the source 
material from that contributed by diluents and other additives and ingredients, individual 
specifications may require a statement of percentage Total Organic Solids (T.O.S.) 
which is defined as follows: 
% T.O.S. = 100 - (A+W+D) 
where A = % ash, W = % water and D = % diluents and/or other additives and 
ingredients. 
The T.O.S. may be expressed as a ratio to the pine active ingredient (i.e.the enzyme 
content). Depending on the product in question the ratio may be very close to 1. 
5. Usage 
Information should be given on: 
5.1 Technological function of the enzyme. 
5.2 Types of foodstuffs in which the enzyme is intended to be used. 
5.3 Maximum amount of enzyme preparation to be used in each foodstuff. 18 Reports of the Scientific Committee for Food: 27th series 
6. Stability and fate in the food 
Information should be given on: 
6.1 Amount of enzyme preparation (i.e. active enzyme as well as other constituents) in the 
final food preparation. 
6.2 Main reaction products and possible reaction products not considered normal 
constituents of the diet, formed during the production and storage of enzyme treated food 
(see point 4 of the general safety issues in the Introduction). 
6.3 Possible effects on nutrients. 
General requirements and specifications 
7. Hygiene 
7.1 Enzyme preparations are to be produced in accordance with good food manufacturing 
practice. The stock cultures of microorganisms used as the sources of enzyme 
preparations should be periodically tested to ensure their purity (see section 2.3). 
7.2 Addition of the enzyme preparation to a foodstuff must not cause any increase in the total 
microbial count in the foodstuff. 
8. Contaminants 
8.1 Heavy metals: Preparations should not contain toxicologically significant amounts of 
heavy metals such as lead, cadmium, arsenic and mercury. The actual levels of heavy 
metals should be stated for each preparation. 
8.2 Microbiological contaminants 
• No pathogenic micro-organisms (eg. Salmonella, Shigella, Escherichia coli, Listeria, 
Campylobacter, Clostridium perfringens) should be detectable using appropriate 
techniques.2 
• Coliforms not more than 30 per gram as determined by a suitable method (eg. ISO 
4832).3 
Ο Λ 
• Total viable count not more than 10 - 10 per gram as determined by a suitable 
method* 
8.3 Tests shall be performed to ensure that viable cells from the microbial source organism 
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8.4 Enzyme preparations may not contain any antibiotic activity as determined by a suitable 
method.
5 
8.5 Enzyme preparations may not contain detectable amounts of toxins. When a given source 
is known to be able to produce toxins the absence of those toxins relevant to the 
organism shall be shown by a suitable method. 
Documentation for safety in use 
9. Basic toxicological requirements 
9.1 For enzymes derived from edible parts of animals or plants no toxicological tests are 
normally required. Where parts which are not generally considered as a normal part of 
the diet are used, some toxicological testing may be required unless other satisfactory 
documentation for safety in use is provided. 
9.2 For enzyme preparations derived from microorganisms the following tests are normally 
required: 
(a) 90-day oral toxicity test in a rodent species; 
(b) Two short-term tests: 
1. a test for gene-mutations in bacteria, 
2. a test for chromosomal aberrations (preferably in vitro). 
The toxicological tests shall, where possible, be performed on a batch from the final 
purified fermentation product, before addition of carriers, diluents, etc. They should, as 
a general rule, be performed in accordance with established guidelines (EC/OECD; see 
also references 8 and
 n) although, because of the effects exerted at the cellular level by 
the proteinaceous nature and/or enzymatic activities of certain enzyme preparations, some 
modifications of the standard test protocols, particularly in the case of in vitro tests, may 
be necessary. Such deviations will be acceptable if accompanied by adequate supporting 
arguments. 
The test system is designed to uncover unspecified toxic reactions and to reveal genotoxic 
effects. The combined information from the general specifications and this test battery make it 
possible to evaluate the product for the presence of both specific, well known toxins and 
unknown toxic compounds. 
The toxicological report shall contain satisfactory documentation that the tests have been 
performed on the material which forms the basis of the commercial product as described in the 
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10. Exemptions from the basic toxicological requirements 
From a toxicological point of view it is important to perform a toxicological testing 
procedure on each specific enzyme preparation produced from a microbiological source. 
10.1 If, however, one enzyme preparation from a specific strain has been thoroughly tested 
and the manufacturing process does not differ significantly for other enzymes from the 
same strain, the full testing battery may be waived for these enzymes. This will be 
decided on a case-by-case basis. 
10.2 If the microorganism used in the production 
- has a long history of safety in food use, and 
- belongs to a species about which it has been documented that no toxins are 
produced, and 
- the actual strain used is of well documented origin, 
the acceptance of an enzyme preparation from this organism without specific 
toxicological testing may be justified. In this case a correct and confirmed identification 
of the organism is of extra importance. 
Presently the Committee can give only one example of such an organism which is 
Saccharomyces cerevisiae. 
Enzyme preparations from such sources still have to comply with the general 
specifications. 
10.3 When a mutant strain is substituted for the original strain of microorganism used in the 
production of an enzyme preparation previously tested and approved, a modified, less 
comprehensive test procedure may be appropriate. Justification for such a reduced 
procedure must be provided on a case-by case basis. 
10.4 In connection with immobilized enzyme preparations, where immobilization techniques 
are evaluated and approved on the basis of adequate toxicity testing, they may be 
combined with previously evaluated and approved enzyme preparations without the need 
for additional toxicity testing on the combined product if analytical data are provided to 
indicate that the leakage of components of the combined product is within acceptable 
limits (see section 4.2). 
10.5 With the introduction of well specified, non-toxin-producing genetically engineered 
source organisms for the production of food enzyme preparations, it may in future be 
possible to produce enzymes of very high purity and specificity. For products where it is 
possible to demonstrate such high purity and specificity, the full toxicity testing may not 
be needed. 
Notwithstanding the circumstances listed above where testing procedures may be acceptable, 
there may be circumstances where additional testing over and above the basic requirements is 
necessary to resolve questions that arise in any of the basic studies. Guidelines for the presentation of data on food enzymes: 11-4-1991 21 
Evaluation of safety in use 
On the basis of technological and toxicological data submitted, the Committee will 
ascertain the safety in use of the enzyme preparation. This may be done either by 
defining the acceptable conditions of use or, when appropriate, by allocating an 
acceptable daily intake for a specified enzyme preparation based on the no-observed-
effect-level in the sub-chronic rodent study with the application of a suitable safety 
factor. 
The evaluation will be confined to the product described in the submission and cannot 
automatically be considered to cover other preparations of the same enzyme prepared 
from other sources or by other processes. 
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December 1990 (restricted). Recommendation on cyclamates 
(Opinion expressed on 21 June 1991) 
1. Following the position recently taken on cyclamate by the UK's Committee on Toxicity 
in the light of new data, the Commission of the European Communities has asked the 
Scientific Committee for Food to review the data available for cyclamic acid and its 
sodium salt to see whether there is any basis for changing its existing opinion. 
The Committee last reviewed cyclamate in 1988 (Reports of the Scientific Committee for 
Food, Twenty-first Series, 1989, EUR 11617). At that time it confirmed its earlier 
decision, reached in 1984, to allocate a group temporary ADI of 0-11 mg/kg bw to 
cyclamic acid and its sodium and calcium salts. The UK Committee on Toxicity has 
allocated a temporary ADI of 0-1.5 mg/kg bw to this sweetener. 
3. In reviewing the data, the Committee noted that itself and the Committee on Toxicity 
agreed on the basic toxicological finding on which they based their ADFs, namely the 
testicular toxicity of cyclohexylamine (the gut floral metabolite of cyclamate) and its no-
observed-effect-level in the rat of 100 mg/kg bw/day. There is also agreement on the 
degree to which cyclamate is absorbed; that the extent of conversion of cyclamate to 
cyclohexylamine varies in different individuals from 0 to 100% of the available 
cyclamate; and that any safety evaluation should take into account especially sensitive 
sub-groups in the population. 
4. The difference in the position taken by the COT to that taken previously by this 
Committee stemmed from the different choice made concerning the extent of conversion 
of cyclamate to cyclohexylamine in the human population and in the choice of safety 
factor to be applied to the NOEL in deriving the ADI. 
Whilst acknowledging the existence of new data, the Scientific Committee for Food is of 
the opinion that the new data do not introduce any significantly novel aspect into the 
consideration of cyclamate. The choice of the appropriate conversion factor in 
combination with the safety factor remains one of judgement. Such a judgement must 
take into account the fact that different individuals in the population convert cyclamate to 
different extents and that the ability of any one individual to convert varies with time. 24 Reports of the Scientific Committee for Food: 27th series 
The Committee is of the view that its previously assumed conversion rate of 30% of the 
available cyclamate (equivalent to 19% of the total ingested) is sufficiently conservative 
to provide adequate assurance of safety for the overwhelming majority of the population 
and re-affirms its view that the safety factor of 100 applied in determining ADI covers 
lifetime exposure and therefore provides sufficient assurance of safety to encompass 
those few individuals who may be converting to a greater extent at any one time.
1" 
In conclusion, the Committee confirms its existing group temporary ADI of 0-11 mg/kg 
bw for cyclamates. Before a full ADI can be established there is a need for more 
information concerning the degree to which cyclamate is converted to cyclohexylamine. 
The Committee requests that studies be carried out to define with greater precision the 
range of extent of conversion in humans with respect to variation with time in any 
individual. Such studies should pay particular attention to the high converters in the 
population. In vitro studies on testicular tissues should also be carried out to determine 
the sensitivity of man relative to species for which data already exist. The results of these 
studies should be available to the Committee by the end of 1992. 
One member (Dr J Steadman ) disagreed with this view. Report on the risks of hypervitaminosis A 
(Opinion expressed on 21 June 1991) 
1. The Committee has examined the available experimental and epidemiological data which 
would permit an evaluation of the risks from hypervitaminosis A. These risks are related 
in the Committee's opinion essentially to a teratogenic effect in women during the first 
two months of pregnancy. 
A teratogenic risk appears possible, albeit very low, from a chronic intake of 20,000 IU 
vitamin A per day and seems likely at doses higher than 50,000 IU per day. The effects 
of a large dose ingested haphazardly are more difficult to estimate. In the present state of 
knowledge it is possible to hypothesise that the teratogenic effect of vitamin A is due to 
an excessive production of retinoic acid which then acts abnormally on those nuclear 
receptors which affect the expression of genes involved in cellular differentiation once 
the binding capacities of retinoic acid to the Cellular Retinoic Acid Binding Protein have 
been exceeded. Under these conditions it is to be feared that the effects of a single, large 
dose of vitamin A would be more important than the same dose divided into regular daily 
ingestions. 
The Committee noted the analytical data, collected in the different Member States, on the 
vitamin A content of the livers of animals raised for human consumption. It also noted 
that levels exceeding 100,000 IU/100 g liver occurred rather frequently and that in 
certain cases even 400,000 RJ/lOO g liver could be reached. 
4. The Committee is of the opinion that such levels constitute a risk for the health of the 
public and that immediate measures should be taken regarding animal husbandry 
practices (eg limitation of the vitamin A content of animal feed, restriction of the practice 
of injecting large doses of vitamin A) in order to reduce rapidly and effectively the 
vitamin A content of the livers sold for consumption. It would be important to reduce the 
vitamin A content of the liver to the lowest possible level compatible with the welfare and 
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5. Until appropriate changes in present day animal husbandry achieve this desired 
objective, the Committee is of the opinion that liver should not be consumed by women 
who are, or who might become, pregnant. The Committee regrets to have to advise that 
such discriminatory action be taken against a food which otherwise possesses undoubted 
nutritional qualities but sees at present no alternative for achieving adequate health 
protection of this particular section of the population. 
6. The developments regarding the vitamin A level of livers should be followed on a 
Community basis by instituting co-ordinated analytical investigations. Scientific 
investigations to clarify the exact nature and size of the risk are also desirable. 
7. The risk of hypervitaminosis A may be aggravated because of the free availability of 
dietary vitamin supplements without medical prescription. The Committee considers it 
advisable to limit the total daily consumption of these vitamin supplements to the 
Recommended Daily Allowance. To achieve this it is necessary to ensure that these 
supplements are labelled appropriately as to their composition and that they carry a 
warning regarding excessive intake, particularly by women who are, or who might 
become, pregnant. 
8. The Committee urges the Commission to take the necessary steps to inform Member 
States about the risk of hypervitaminosis A from food and the use of vitamin A and the 
retinoids for any other purposes. The Scientific Committee for Food was established by Commission Decision 74/234/EEC 
of 16 April 1974 (OJ L 136,20.5.1974, page 1) to advise the Commission on any problem 
relating to the protection of the health and safety of persons arising from the consumption of 
food, and in particular the composition of food, processes which are liable to modify food, 
the use of food additives and other processing aids as well as the presence of contaminants. 
The members are independent persons, highly qualified in the fields associated with 
medicine, nutrition, toxicology, biology, chemistry, or other similar disciplines. 
The Secretariat of the Committee is provided by the Directorate-General for Internal Market 
and Industrial Affairs of the Commission. Recent Council directives require the 
Commission to consult the Committee on provisions which may have an effect on public 
health falling within the scope of these directives. 
The present repon deals with foods intended for weight control diets (opinion 
expressed on 19 October 1990), guidelines for the presentation of data on food 
enzymes (opinion expressed on 11 April 1991), a recommendation on cyclamates 
(opinion expressed on 21 June 1991) anda report on the risks of hypervitaminosis 
A (opinion expressed on 21 June 1991). For up-to-date information on 
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